Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 4 Balance test for related clinical materials before treatment

		Combined with ascites liquid	Combined with hepatic encephalopathy	Combined with infection	Combined with liver cancer
Fib (1.6-2.0 g/L) level	Research group	10	0	8	5
	Control group	15	3	15	2
	P value	0.190	0.236	0.063	0.421
Fib (1.1-1.5 g/L) level	Research group	17	1	10	6
	Control group	20	0	13	2
	P value	0.426	1.000	0.426	0.255
Fib ( ≤ 1.0 g/L) level	Research group	8	1	4	0
	Control group	12	1	5	1
	P value	1.000	1.000	0.734	1.000

Anyone in the three subgroups divided by standard Fib level, and clinical materials such as complications was balanced between research and control groups before treatment.